RMIT and GonGlobal partner to replace IVF injections with inhaled medicines

RMIT and GonGlobal partner to replace IVF injections with inhaled medicines

RMIT University researchers are working with Melbourne company GonGlobal to develop an inhaled alternative to in vitro fertilisation (IVF) injections, a change that could make treatment dramatically easier for patients.

IVF can be a long and taxing process. Most patients need three to six treatment cycles to achieve a live birth, and each cycle involves multiple self-administered injections.

For many people, that adds up to hundreds of injections over the course of their treatment. 

Distinguished Professor Leslie Yeo, who is leading the RMIT side of the collaboration, said the treatment burden was a key motivation for the project. 

The four leaders stand together in a lab.(L-R) RMIT University Deputy Vice-Chancellor Research and Innovation, Distinguished Professor Calum Drummond AO, Minister for Economic Development, Anthony Carbines, Distinguished Professor Leslie Yeo and GonGlobal Co-Founder and CEO, Ellen Gonda. Credit: Seamus Daniel.

"IVF has created millions of lives, but the treatment itself can be incredibly demanding," Yeo said. "We're excited to work with GonGlobal to develop technology that could replace injections with inhaled medicines and make IVF significantly easier for patients." 

The collaboration between RMIT and GonGlobal will develop OVULAIR™, a system designed to deliver IVF medicines by inhalation instead of injection. 

It's built on RMIT's patented HYDRA inhalation technology, which uses a nebulizer to deliver liquid medicines deep into the lungs safely and selectively. GonGlobal has secured an exclusive global licence to apply the technology to fertility drugs.

"By combining RMIT's engineering expertise with GonGlobal's experience in therapeutic drug-device combination development and commercialisation, we're developing a solution that has the potential to change the IVF experience for patients around the world," Yeo said. 

Minister for Economic Development Anthony Carbines and Distinguished Professor Leslie Yeo. Credit: Seamus Daniel.Minister for Economic Development Anthony Carbines and Distinguished Professor Leslie Yeo. Credit: Seamus Daniel.

The project has attracted $1 million in funding, with RMIT and Innovation Victoria each contributing $500,000, to support the development and commercialisation of OVULAIR™.

Victoria's Minister for Economic Development, Anthony Carbines, said the project reflects the state's ambitions in health innovation.

"This innovation shows what Victoria can do – taking world-class research and turning it into a global breakthrough that can change lives," he said. 

"We're backing Victoria's brightest innovators to scale faster, attract global investment and prove that the world's best ideas come from right here in Melbourne.” 

RMIT's Deputy Vice-Chancellor Research and Innovation, Distinguished Professor Calum Drummond AO, said the partnership reflects the value of collaboration across sectors. 

"Transformative research doesn't happen in isolation, it happens when universities, industry and government bring their complementary strengths together," Drummond said. 

"This partnership with GonGlobal, backed by Innovation Victoria, is a powerful example of how we can move breakthrough technologies out of the lab and into the clinic, where they have the potential to deliver significant benefits for patients and strengthen Victoria's medical innovation ecosystem."

Calum Drummond speaks with 9 News RMIT University Deputy Vice-Chancellor Research and Innovation, Distinguished Professor Calum Drummond AO speaking with 9 News. Credit: Seamus Daniel.

For GonGlobal Co-Founder and CEO Ellen Gonda, the work is personal. 

"I know firsthand how challenging it can be for patients experiencing infertility and navigating IVF," she said. 

"The physical, emotional, logistical and financial tolls can be overwhelming. Our mission is simple, to radically improve the IVF patient experience and success rates by making treatments less painful, more precise and far more joyful." 

GonGlobal Executive Chair, Chief Scientist and Co-Founder Dr Igor Gonda sees the collaboration as a continuation of Melbourne's long history in the field. 

"Melbourne has been a global leader in IVF since the very beginning," Gonda said. 

"We're proud to work with RMIT to continue this tradition by developing a new generation of patient-focused fertility treatments." 

The RMIT and GonGlobal teams will continue developing and testing OVULAIR™ as part of the push toward commercialisation. 

 

Story: Georgina Patterson and Bree Marsh

01 September 2026

Share

Return to RMIT News
01 September 2026

Share

  • Research
  • Announcements
  • Science and technology
Engage

Related News

fringe-deepens-partnerships-thumbnail2-1220x732px.jpg

RMIT and Melbourne Fringe deepen partnership in 2026

RMIT University and Melbourne Fringe brought together experimental design, accessibility, student learning and live performance, building on a partnership that spans many years.

Sleeptite-rmit-team.jpg

Australian smart bedding flags risk of falls, secures US patent

Melbourne-based medtech company Sleeptite and RMIT University researchers have secured a US patent for smart bedding technology designed to monitor residents’ wellbeing in healthcare settings and identify falls risk so carers can intervene.

derby-mou.jpg

RMIT signs MoU with the University of Derby to strengthen international research partnerships

RMIT University has signed a Memorandum of Understanding with The University of Derby in England to strengthen its international research collaboration.

scape-peer-support-image2-1220x732px.jpg

Peer Support: The Power of Students Helping Students

RMIT University and Scape by The Living Company have co-created a peer support program which allows RMIT social work students to complete their placement and work as peer support workers within Scape residencies.

Show more
aboriginal flag float-starttorres strait flag float-start

Acknowledgement of Country

RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business - Artwork 'Sentient' by Hollie Johnson, Gunaikurnai and Monero Ngarigo.

More information